Cleared Traditional

K193246 - Stat Profile Prime Plus Analyzer System

K193246 is the FDA 510(k) clearance for Stat Profile Prime Plus Analyzer System by Nova Biomedical Corporation. It is a Class 2 Chemistry device (product code CHL) cleared through the Traditional 510(k) pathway after a 60-day FDA review.

K193246 · Nova Biomedical Corporation · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2020
Decision
60d
Days
Class 2
Risk

K193246 is an FDA 510(k) clearance for the Stat Profile Prime Plus Analyzer System. Classified as Electrode Measurement, Blood-gases (pco2, Po2) And Blood Ph (product code CHL), Class II - Special Controls.

Submitted by Nova Biomedical Corporation (Walham, US). The FDA issued a Cleared decision on January 24, 2020 after a review of 60 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1120 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Nova Biomedical Corporation devices

Submission Details

510(k) Number K193246 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 25, 2019
Decision Date January 24, 2020
Days to Decision 60 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
28d faster than avg
Panel avg: 88d · This submission: 60d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code CHL Electrode Measurement, Blood-gases (pco2, Po2) And Blood Ph
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1120
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - CHL Electrode Measurement, Blood-gases (pco2, Po2) And Blood Ph

All 114
Devices cleared under the same product code (CHL) and FDA review panel - the closest regulatory comparables to K193246.
epoc Blood Analysis System
K200107 · Epocal, Inc. · Jun 2020
i-STAT CG4+ Cartridge with the i-STAT 1 System
K200492 · Abbott Point of Care, Inc. · Apr 2020
RAPIDPoint 500e Blood Gas System
K192240 · Siemens Healthcare Diagnostics, Inc. · Mar 2020
Stat Profile Prime Plus Analyzer System
K173797 · Nova Biomedical Corporation · Jul 2018
GEM Premier 5000
K173403 · Instrumentation Laboratory CO · Dec 2017
GEM Premier 5000 (Measured Parameters: pH, pCO2 and pO2)
K160412 · Instrumentation Laboratory CO · Dec 2016